On May 26, 2023, Sun Pharmaceutical proposed via a letter to Taro's Board of Directors a non-binding indication of interest to acquire all of the outstanding ordinary shares in Taro, other than any shares already held by the company or its affiliates, for a purchase price of $38 per share, in cash.
Related Keywords
Sun Pharma , Taro Pharmaceutical Industries , Sun Pharmaceuticals , Sun Pharmaceutical , Special Committee , Sun Pharma Taro Deal , Sun Pharmaceuticals Share Price , Taro Pharma , Taro Pharma Offer Price ,
comparemela.com © 2020. All Rights Reserved.